Explain this page
Arphra AIPlain-English read on Ionis Pharmaceuticals, Inc.’s valuation06-08today
- Ionis Pharmaceuticals, Inc. (IONS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript11d
- Ionis announces appointment of Ludwig Hantson, Ph.D. to Board of Directors13d
- Ionis announces appointment of Ludwig Hantson, Ph.D. to Board of Directors13d
- Ionis announces appointment of Ludwig Hantson, Ph.D. to Board of Directors13d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $109.44 (+47.65%)
Candlestick · 1Y
Open in chart workstation →IONS
74.12+96.76%H 86.74L 36.93MA50 74.90MA200 75.00Avg vol 2.2M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.26% | +1.41% | -1.91% | +4.41% | -8.88% | -6.31% | +96.76% | +79.90% | +96.66% | +228.11% | +641.20% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$74.00
1 sh
Bid
$73.53
300 sh
Ask
$75.00
150 sh
Spread
$1.470
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.51%
- Communication Services+1.85%
- Utilities+1.35%
- Consumer Cyclical+0.30%
- Consumer Defensive-0.30%
- Energy-0.45%
- Industrials-0.48%
- Basic Materials-0.66%
- Financial Services-0.67%
- Real Estate-0.99%
- Healthcare-1.51%
Top industries (issuer's industry highlighted)
- Biotechnology+0.28%
- Oil & Gas Energy+8.53%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Electronic Gaming & Multimedia+5.23%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Grocery Stores-4.35%
- Financial - Mortgages+4.08%
- Broadcasting+4.00%
- Computer Hardware-3.67%
- Internet Content & Information+3.58%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Ionis Pharmaceuticals, Inc. (IONS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 10, 2026
- Ionis announces appointment of Ludwig Hantson, Ph.D. to Board of Directorsgurufocus.com·Jun 08, 2026
- Ionis announces appointment of Ludwig Hantson, Ph.D. to Board of Directorsbusinesswire.com·Jun 08, 2026
- Ionis announces appointment of Ludwig Hantson, Ph.D. to Board of Directorsbusinesswire.com·Jun 08, 2026
- Ionis Pharmaceuticals, Inc. (IONS) Discusses Progress in RNA Therapeutics and Transition to Commercial-Stage Biotechnology Transcriptseekingalpha.com·Jun 05, 2026
- Ionis to present new analyses from CORE and CORE2 pivotal studies supporting olezarsen for severe hypertriglyceridemia (sHTG) at upcoming congressesbusinesswire.com·Jun 04, 2026
- Ionis to present new analyses from CORE and CORE2 pivotal studies supporting olezarsen for severe hypertriglyceridemia (sHTG) at upcoming congressesbusinesswire.com·Jun 04, 2026
- Ionis Pharmaceuticals, Inc. (IONS) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
Peers
No peer list available for IONS.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|